4//SEC Filing
Moshkevich Solomon 4
Accession 0002010019-25-000012
CIK 0001604821other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 9:35 PM ET
Size
8.8 KB
Accession
0002010019-25-000012
Insider Transaction Report
Form 4
Natera, Inc.NTRA
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Transactions
- Sale
Common Stock
2025-11-03$198.03/sh−1,450$287,138→ 113,611 total - Sale
Common Stock
2025-11-03$199.10/sh−1,450$288,698→ 112,161 total - Sale
Common Stock
2025-11-03$199.74/sh−100$19,974→ 112,061 total
Footnotes (3)
- [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.71 to $199.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Natera, Inc.
CIK 0001604821
Entity typeother
Related Parties
1- filerCIK 0002010019
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 9:35 PM ET
- Size
- 8.8 KB